Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases

Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases

Patients with obstructive airway diseases (OAD), like chronic obstructive pulmonary disease (COPD) and asthma, may be at increased risk of pertussis infection. Pertussis may also trigger COPD and asthma exacerbations. Vaccination against pertussis could help protect OAD patients from the additional...

Full description

Bibliographic Details
Main Authors: Peter Van den Steen, Brigitte Cheuvart, Quentin Deraedt, Laura Valdes Verelst, Dasha Shamarina
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
copd
asthma
obstructive airway diseases
pertussis
dtap
tdap
vaccination
adults
immunogenicity
safety
Online Access:http://dx.doi.org/10.1080/21645515.2022.2159731

Internet

http://dx.doi.org/10.1080/21645515.2022.2159731

Similar Items